Aclarion, Inc. (ACON)
NASDAQ: ACON · Real-Time Price · USD
3.260
-0.010 (-0.31%)
At close: Mar 9, 2026, 4:00 PM EDT
3.270
+0.010 (0.31%)
After-hours: Mar 9, 2026, 5:20 PM EDT
Aclarion Revenue
Aclarion had revenue of $18.94K in the quarter ending September 30, 2025, with 31.48% growth. This brings the company's revenue in the last twelve months to $67.48K, up 36.91% year-over-year. In the year 2024, Aclarion had annual revenue of $45.72K, down -39.36%.
Revenue (ttm)
$67.48K
Revenue Growth
+36.91%
P/S Ratio
41.27
Revenue / Employee
$11,247
Employees
6
Market Cap
2.79M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Forian | 28.11M |
| DarioHealth | 24.73M |
| VSee Health | 14.43M |
| Zhongchao | 13.12M |
| Healthcare Triangle | 12.94M |
| Mobile-health Network Solutions | 7.65M |
| SCWorx | 2.78M |
| OneMedNet | 494.00K |
ACON News
- 3 months ago - Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S. - GlobeNewsWire
- 4 months ago - Aclarion Wins “Rising Star” at 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH - GlobeNewsWire
- 5 months ago - Aclarion to Present at the LD Micro Main Event XIX - Newsfile Corp
- 9 months ago - Aclarion to Present NOCISCAN Technology at Leading Spine Innovation Forum - GlobeNewsWire
- 10 months ago - Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site - GlobeNewsWire
- 10 months ago - Aclarion Announces Texas Back Institute as New CLARITY Trial Site - GlobeNewsWire
- 11 months ago - Aclarion Announces Commercial Agreement with Spine Institute of Louisiana - GlobeNewsWire
- 11 months ago - Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025 - GlobeNewsWire